Scalable delivery of gene therapy.
Immunotherapies are the most promising development for cancer, in particular those based on personalising treatments using the patient’s cells.
Indee Labs has developed a scalable process using a microfluidic chip that inserts genetic therapies into human cells to help deliver cures to cancer and other diseases.
December 2017. Seed. Lead Partner: Mike Nicholls
Founders Fund, Social Capital, Y-Combinator